Keigo Gohda

877 total citations
50 papers, 676 citations indexed

About

Keigo Gohda is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Keigo Gohda has authored 50 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Keigo Gohda's work include Protein Structure and Dynamics (10 papers), Protease and Inhibitor Mechanisms (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Keigo Gohda is often cited by papers focused on Protein Structure and Dynamics (10 papers), Protease and Inhibitor Mechanisms (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Keigo Gohda collaborates with scholars based in Japan, United States and Switzerland. Keigo Gohda's co-authors include Naoki Teno, Ko Fujimori, Yukiko Yamashita, Jun Sato, Toshio Hakoshima, Yuko Tsuda, Keiko Wanaka, Tomoko Matsushima, Hideki Ishihara and Katsuhiro Murakami and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and The Journal of Physical Chemistry B.

In The Last Decade

Keigo Gohda

49 papers receiving 668 citations

Peers

Keigo Gohda
Satish K. Chitneni United States
Richard L. Hayward United Kingdom
Narges K. Tafreshi United States
Hemant Parekh United States
Hank La United States
Paramita Chakraborty United States
Keigo Gohda
Citations per year, relative to Keigo Gohda Keigo Gohda (= 1×) peers Manuela Gridling

Countries citing papers authored by Keigo Gohda

Since Specialization
Citations

This map shows the geographic impact of Keigo Gohda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keigo Gohda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keigo Gohda more than expected).

Fields of papers citing papers by Keigo Gohda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keigo Gohda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keigo Gohda. The network helps show where Keigo Gohda may publish in the future.

Co-authorship network of co-authors of Keigo Gohda

This figure shows the co-authorship network connecting the top 25 collaborators of Keigo Gohda. A scholar is included among the top collaborators of Keigo Gohda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keigo Gohda. Keigo Gohda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Teno, Naoki, Keisuke Oda, Yukiko Yamashita, et al.. (2021). Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum. ACS Medicinal Chemistry Letters. 12(3). 420–425. 15 indexed citations
4.
Gohda, Keigo, Ko Fujimori, Yukiko Yamashita, et al.. (2020). N1-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR). Bioorganic & Medicinal Chemistry. 28(14). 115512–115512. 9 indexed citations
6.
Teno, Naoki, et al.. (2017). Discovery and optimization of benzimidazole derivatives as a novel chemotype of farnesoid X receptor (FXR) antagonists. Bioorganic & Medicinal Chemistry. 25(6). 1787–1794. 7 indexed citations
7.
Ito, Hiroaki, Jun Sato, Noriko Yamaguchi, et al.. (2016). Long-term prognostic impact of circulating tumour cells in gastric cancer patients. World Journal of Gastroenterology. 22(46). 10232–10232. 16 indexed citations
8.
Teno, Naoki, Keigo Gohda, Yukiko Yamashita, et al.. (2016). Plasmin inhibitors with hydrophobic amino acid-based linker between hydantoin moiety and benzimidazole scaffold enhance inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 26(9). 2259–2261. 8 indexed citations
9.
Igawa, Satoshi, Keigo Gohda, Tomoya Fukui, et al.. (2014). Circulating tumor cells as a prognostic factor in patients with small cell lung cancer. Oncology Letters. 7(5). 1469–1473. 56 indexed citations
10.
Teno, Naoki, Keigo Gohda, Keiko Wanaka, et al.. (2014). Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4/S4 interaction on plasmin. Bioorganic & Medicinal Chemistry. 22(7). 2339–2352. 10 indexed citations
11.
Gohda, Keigo, Michelle L. Davis, W. Fraser Symmans, et al.. (2013). Novel Functional Assay for Spindle-Assembly Checkpoint by Cyclin-Dependent Kinase Activity to Predict Taxane Chemosensitivity in Breast Tumor Patient. Journal of Cancer. 4(9). 697–702. 5 indexed citations
12.
Teno, Naoki, Keigo Gohda, Keiko Wanaka, Takuya Sueda, & Yuko Tsuda. (2011). Identification of novel plasmin inhibitors possessing nitrile moiety as warhead. Bioorganic & Medicinal Chemistry Letters. 21(21). 6305–6309. 9 indexed citations
13.
Nes, Johanna G. H. van, Vincent T.H.B.M. Smit, Hein Putter, et al.. (2009). Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients. British Journal of Cancer. 100(3). 494–500. 11 indexed citations
14.
Tsutsumi, Ken‐ichi, et al.. (2008). Species Differences Between Human and Rat in the Substrate Specificity of Cathepsin K. The Journal of Biochemistry. 144(4). 499–506. 7 indexed citations
15.
Teno, Naoki, et al.. (2008). New chemotypes for cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2599–2603. 12 indexed citations
16.
Urata, Hidehito, et al.. (2004). Synthesis and hybridization properties ofl-oligodeoxynucleotide analogues fixed in a low anti glycosyl conformation. Organic & Biomolecular Chemistry. 2(2). 183–189. 6 indexed citations
17.
Hiramoto, Takeshi, Yosuke Nonaka, Kazuko Inoue, et al.. (2004). Identification of Endogenous Surrogate Ligands for Human P2Y Receptors Through an In Silico Search. Journal of Pharmacological Sciences. 95(1). 81–93. 17 indexed citations
18.
Gohda, Keigo, Yoko Kimura, Ichiro Mori, Daisaku Ohta, & Takeshi Kikuchi. (1998). Theoretical evidence of the existence of a diazafulvene intermediate in the reaction pathway of imidazoleglycerol phosphate dehydratase: design of a novel and potent heterocycle structure for the inhibitor on the basis of the electronic structure-activity relationship study. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1385(1). 107–114. 16 indexed citations
19.
Gohda, Keigo, Takeshi Itoh, Ken‐ichi Tomita, et al.. (1993). Crystal Structure of RNase T1(Y45W) Complexed with 3' AMP and Gf1pA. The Journal of Biochemistry. 114(6). 842–848. 1 indexed citations
20.
Hakoshima, Toshio, Takeshi Itoh, Keigo Gohda, et al.. (1991). Non‐cognizable ribonucleotide, 2′AMP, binds to a mutant ribonuclease T1 (Y45W) at a new base‐binding site but not at the guanine‐recognition site. FEBS Letters. 290(1-2). 216–220. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026